NCT04992429 is a clinical trial of SphinkeeperTM in Fecal Incontinence, sponsored by Medical University of Vienna.

Who is sponsoring NCT04992429?

NCT04992429 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04992429?

Interventions in NCT04992429: SphinkeeperTM.

What condition does NCT04992429 study?

NCT04992429 studies Fecal Incontinence.

Is NCT04992429 still recruiting?

NCT04992429 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT04992429

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Do Prostheses of SphinkeeperTM Migrate After Operation?

Completed Last updated 18 January 2023

What this trial tests

trial testing SphinkeeperTM in Fecal Incontinence in 32 participants. Completed in 18 June 2021.

Timeline

1 June 2020

Primary endpoint
18 June 2021

18 June 2021

Quick facts

Lead sponsor	Medical University of Vienna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	32
Start date	1 June 2020
Primary completion	18 June 2021
Estimated completion	18 June 2021
Sites	1 location across Austria

Drugs / interventions tested

SphinkeeperTM

Conditions studied

Fecal Incontinence — all drugs for Fecal Incontinence →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 90, any sex, with Fecal Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

32 patients who underwent sphinkeeper operation got enrolled in this study. The primary endoint is to explore the movement of the prostheses examined by manometry and ultrasound. The secondary endpoint is to find out about the functional outcome when migration of prostheses occurs and to examine differences in morphology of the sphincters after operation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Endosonographic monitoring of Sphinkeeper<sup>®</sup> prostheses movements: does physical activity have an impact?
Dawoud C, Gidl D, Widmann KM, Pereyra D, et al · · 2024 · cited 3× · PMID 37640968 · DOI 10.1007/s13304-023-01636-y
Long-term outcome after SphinKeeper® surgery for treating fecal incontinence-who are good candidates?
Dawoud C, Widmann KM, Pereyra D, Harpain F, et al · · 2023 · cited 2× · PMID 38052934 · DOI 10.1007/s00423-023-03188-6

Verify or expand the search:

Other recruiting trials for Fecal Incontinence

Currently open trials in the same condition.

NCT06532123 — Mechanisms of Improving Fecal Continence Muscles Motor Function · NA · recruiting
NCT05998187 — Mechanisms of Action on Rectal Motricity of Intrarectal Botulinum Toxin Injections · Phase 3 · recruiting
NCT06754189 — Safety and Performance of UCon Patch Electrode · NA · recruiting
NCT06562140 — Multidimensional Examination of Patients with Colorectal and Anal Cancer · recruiting
NCT06273046 — Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback · NA · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04992429 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04992429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing